Target RWE Registries
Target RWE Registry Framework
The Target RWE model utilizes a multi-disciplinary approach to developing, managing, and sustaining the growth of disease-specific registries. This includes conducting extensive research as well as the leveraging the guidance and expertise from our academic, advisory, and publications committees, which is formed, organized and overseen by Target RWE.
Academic Steering Committee
Each Target RWE therapeutic-aligned registry begins with the formation of an academic steering committee comprised of disease experts and world-class key opinion leaders who guide the development and design of the study protocol and research plan. The steering committee provides perpetual expertise and feedback to ensure the successful growth and progress of each registry.
For each disease-specific registry, Target RWE has established an advisory committee comprised of industry partners, regulatory agency representatives, and patient advocacy groups to strengthen understandings of the disease, discuss challenges of each disease state, and promote the advancement of the field.
Target RWE collaborates with key stakeholders including industry partners, principal investigators, and academic steering committee members to publish peer-reviewed abstracts and manuscripts addressing scientific gaps and latest data findings from Target RWE's disease-specific registries. Target RWE findings have been presented at national and international scientific and medical conferences, and have been published in numerous high-quality peer-reviewed journals.